SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-168821
Filing Date
2022-06-07
Accepted
2022-06-07 07:17:31
Documents
14
Period of Report
2022-06-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d345163d8k.htm   iXBRL 8-K 38110
2 EX-99.1 d345163dex991.htm EX-99.1 5986
6 GRAPHIC g345163g0606232842125.jpg GRAPHIC 2997
  Complete submission text file 0001193125-22-168821.txt   171417

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rgnx-20220603.xsd EX-101.SCH 2850
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgnx-20220603_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgnx-20220603_pre.xml EX-101.PRE 10808
8 EXTRACTED XBRL INSTANCE DOCUMENT d345163d8k_htm.xml XML 3227
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37553 | Film No.: 22999804
SIC: 2836 Biological Products, (No Diagnostic Substances)